Detalles de la búsqueda
1.
Characterization of a functional V1B vasopressin receptor in the male rat kidney: evidence for cross talk between V1B and V2 receptor signaling pathways.
Am J Physiol Renal Physiol
; 321(3): F305-F321, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34282956
2.
Proinflammatory role of vasopressin through V1b receptors in hapten-induced experimental colitis in rodents: implication in IBD.
Am J Physiol Gastrointest Liver Physiol
; 299(6): G1298-307, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20864658
3.
Pharmacological and physiological characterization of d[Leu4, Lys8]vasopressin, the first V1b-selective agonist for rat vasopressin/oxytocin receptors.
Endocrinology
; 148(9): 4136-46, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17495006
4.
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms.
Eur J Pharmacol
; 501(1-3): 59-69, 2004 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-15464063
5.
Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress.
Ann N Y Acad Sci
; 1148: 349-59, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19120128
6.
Biological characterization of rodent and human vasopressin V1b receptors using SSR-149415, a nonpeptide V1b receptor ligand.
Am J Physiol Regul Integr Comp Physiol
; 293(2): R938-49, 2007 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-17522130
7.
PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
J Am Soc Nephrol
; 18(6): 1740-53, 2007 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-17475819
8.
An overview of SSR149415, a selective nonpeptide vasopressin V(1b) receptor antagonist for the treatment of stress-related disorders.
CNS Drug Rev
; 11(1): 53-68, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-15867952
9.
Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.
Am J Physiol Endocrinol Metab
; 285(3): E566-76, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-12736162
10.
Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals.
Stress
; 6(3): 199-206, 2003 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-13129813
11.
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Proc Natl Acad Sci U S A
; 99(9): 6370-5, 2002 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-11959912
12.
Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist.
J Pharmacol Exp Ther
; 300(3): 1122-30, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11861823
13.
SSR126768A (4-chloro-3-[(3R)-(+)-5-chloro-1-(2,4-dimethoxybenzyl)-3-methyl-2-oxo-2,3-dihydro-1H-indol-3-yl]-N-ethyl-N-(3-pyridylmethyl)-benzamide, hydrochloride): a new selective and orally active oxytocin receptor antagonist for the prevention of preterm labor.
J Pharmacol Exp Ther
; 309(1): 414-24, 2004 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-14722330
Resultados
1 -
13
de 13
1
Próxima >
>>